Navigation Links
Successful FDA Inspection at AXIS Clinicals USA
Date:8/16/2017

We are proud to announce the successful completion of our third U.S. Food and Drug Administration (FDA) inspection at our Dilworth, MN site. The inspection took place Monday, July 31st through Friday, August 4th, 2017. No 483 was issued. This inspection was conducted as part of a routine Bioresearch Monitoring Program (BIMO) with the USFDA wherein multiple Dermatology Vasoconstriction Bioequivalence studies were reviewed by the inspector.

AXIS has completed 19 successful FDA inspections at our Hyderabad, India and Dilworth, MN sites for USFDA submission studies, including First-To-File and patient based clinical studies. This recent success is another accomplishment as it reinforces our commitment to Quality and International Regulatory Compliance.

“It feels great to have two successful FDA audits without a 483 issued in a span of less than three months. The most recent audit focused on Dermatology which has been a business focus for AXIS since our inception and we have invested heavily to build our capabilities and serve our customer’s needs. We are very pleased with the positive feedback given by the FDA regarding our staff competence, as well as the robust company processes and documentation practices.” –Dinkar Sindhu, CEO

About AXIS Clinicals

AXIS Clinicals USA, a full-service Contract Research Organization (CRO), is joined by other global sites, AXIS Mexico (Est. 2010) and AXIS India (Headquarters, Est. 2004). AXIS USA offers the conveniences of a purpose-built 120,000 square foot facility to handle multiple studies at once, including an in-house Bioanalytical lab capable of handling over 15,000 samples per month, an on-site Dermatology Center, and a fully licensed Pharmacy. Since opening in 2014, AXIS USA has conducted around 100 studies and dosed over 5,000 volunteers at our Dilworth, MN site. With our global locations, we offer the flexibility and convenience of working with one company across multiple countries.

Contact
To learn more about AXIS Clinicals, please contact: BD(at)AxisClinicalsUSA.com
USA: http://www.axisclinicalsusa.com Corporate: http://www.axisclinicals.com

Read the full story at http://www.prweb.com/releases/2017/08/prweb14603135.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug
2. Grassroots Effort Proving Successful in Solving Multiple Sclerosis Puzzle
3. First Published Clinical Study Successfully Uses Precision Medicine To Predict Prescription Opioid Abuse
4. SkylineDx Presented New Algorithm Demonstrating Ability to Successfully Identify Gene Sets that are Informative of Cancer Treatment Specific Survival
5. RepliCels Successful RCT-01 Tendon Repair Clinical Trial Shows Signs of Healing Chronic Tendon Problems
6. Nanomedical Diagnostics Announces Partnership with Rogue Valley Microdevices, Delivering World’s First Successful High-Volume Manufacturing for Graphene Biosensors
7. JALA Group Announces Successful Printing of Asian Skin Using 3D Bioprinting Technology
8. Malaria Drug Successfully Treats 26-year-old Brain Cancer Patient
9. Resverlogix Announces Successful Phase 1 Renal Trial Results: Clears Path for Future Phase 2 Studies
10. ValGenesis Inc. Successfully Completes ISO 9001:2008 Surveillance Audit
11. BioLineRx Reports Successful Top-Line Results in Phase 2 Trial for AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):